A case of esophageal granular cell tumor diagnosed by mucosal incision-assisted biopsy

Yasuhiro Inokuchi1, Mamoru Watanabe2, Kei Hayashi2

  • 1Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan. inokuchiy@kcch.jp.

Insights

Diagnosing esophageal granular cell tumors (GCTs) requires adequate tissue. Mucosal incision-assisted biopsy (MIAB) provides a simple method to obtain sufficient specimens when other techniques fail.

Area of Science:

  • Gastroenterology
  • Oncology
  • Surgical Pathology

Background:

  • Esophageal submucosal masses require definitive diagnosis, often via immunohistochemistry.
  • Granular cell tumors (GCTs) are a type of esophageal submucosal mass.
  • Accurate diagnosis of GCTs depends on obtaining sufficient biopsy material.

Observation:

  • Forceps biopsy and endoscopic ultrasound-fine needle aspiration (EUS-FNA) can yield insufficient tissue samples for GCT diagnosis.
  • EUS-FNA may present challenges in acquiring adequate tumor material.
  • Mucosal incision-assisted biopsy (MIAB) is a technique for collecting larger biopsy specimens.

Findings:

  • MIAB is a straightforward method to obtain larger tissue samples compared to forceps biopsy or EUS-FNA.
  • The presented case successfully diagnosed an esophageal GCT using MIAB.
  • MIAB addresses the challenge of inadequate specimen yield in diagnosing esophageal GCTs.

Implications:

  • MIAB can improve diagnostic yield for esophageal submucosal masses suspicious for GCT.
  • This technique offers a valuable alternative for obtaining adequate biopsy material when standard methods are insufficient.
  • Successful MIAB facilitates timely and accurate diagnosis and subsequent management of esophageal GCTs.